Tarsus Pharmaceuticals, Inc. Common Stock (TARS) is a publicly traded Healthcare sector company. As of September 2, 2026, TARS trades at $74.10 with a market cap of $3.26B and a P/E ratio of -46.52. TARS moved -0.19% today. Year to date, TARS is -8.32%; over the trailing twelve months it is +26.39%. Its 52-week range spans $38.51 to $85.25. Analyst consensus is strong buy with an average price target of $95.71. Rallies surfaces TARS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TARS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TARS recently traded at $74.10. Market cap is $3.26B. P/E ratio is -46.52. Revenue is $451.36M.
| Metric | Value |
|---|---|
| Price | $74.10 |
| Market Cap | $3.26B |
| P/E Ratio | -46.52 |
| EPS | $-1.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.25 |
| 52-Week Low | $38.51 |
| Volume | 459.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $451.36M |
| Net Income | $-66.42M |
| Gross Margin | 0.00% |
8 analysts cover TARS: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $95.71.